Tilray Brands (TLRY) Profit After Tax Growth (5y) (2024 - 2026)

Tilray Brands (TLRY) Profit After Tax Growth (5y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Tilray Brands 454.65 Mn 394.45 Mn 54.95 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 35.76%
Nov 30, 2025 15.41%
Aug 31, 2025 15.61%
May 31, 2025 -70.71%
May 31, 2024 -11.36%